Latest debt-to-equity ratio
TriSalus Life Sciences Debt-to-equity ratio
Direct answer
TriSalus Life Sciences's debt-to-equity ratio is 525.59%.
The verified market snapshot reports 525.59%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free TriSalus Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 525.59%